172@29@16@14!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=1&is_responsive=1&sec=&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
you are here:

Brooks Laboratories Ltd.

BSE: 533543 | NSE: BROOKS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE650L01011 | SECTOR: Pharmaceuticals

BSE Live

Sep 24, 15:32
59.55 2.80 (4.93%)
Volume
AVERAGE VOLUME
5-Day
18,560
10-Day
11,724
30-Day
9,506
35,566
  • Prev. Close

    56.75

  • Open Price

    58.35

56.70

Today’s L/H

59.55
14.05

52 Wk L/H

59.55
53.95

L/U Price Band

59.55
  • Bid Price (Qty.)

    59.55 (12387)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    58.66
     Beta
    0.46
  • Market Depth (24 Sep 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    18920 59.55 0.00 0
    2 59.50 0.00 0
    601 59.00 0.00 0
    1000 58.80 0.00 0
    1002 58.50 0.00 0
    12486 Total Total 0
     Market Depth
    BUY 12.49 K
    SELL 0
    0%
    0%

NSE Live

Sep 24, 15:32
59.30 2.80 (4.96%)
Volume
AVERAGE VOLUME
5-Day
75,048
10-Day
53,735
30-Day
43,484
73,769
  • Prev. Close

    56.50

  • Open Price

    58.30

56.50

Today’s L/H

59.30
13.85

52 Wk L/H

59.30
53.70

L/U Price Band

59.30
  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    58.63
     Beta
    0.44
  • DELIVERY AVERAGES
    3-Day
    73.26%
    5-Day
    76.20%
    8-Day
    76.64%
    Deliverables
  • SMA
    30
    42.16
    50
    38.49
    150
    30.52
    200
    30.15
    SMA
    42.16
Powered by Trendlyne

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Very Bullish
Moving Averages Bullish
Technical Indicators Bullish
Moving Averages Crossovers Bullish
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 56.83 57.17 57.83 56.17 55.83 55.17 54.83
Fibonacci 56.55 56.78 57.17 56.17 55.78 55.55 55.17
Camarilla 56.59 56.68 56.78 56.17 56.41 56.32 56.22

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 54.02
10 48.36
20 43.90
50 39.10
100 34.56
200 30.33
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels

Type R1 R2 R3 PP S1 S2 S3
Classic 52.75 56.35 63.55 45.55 41.95 34.75 31.15
Fibonacci 49.68 52.22 56.35 45.55 41.42 38.88 34.75
Camarilla 50.14 51.13 52.12 45.55 48.16 47.17 46.18

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 44.90 52.10 58.80 38.20 31.00 24.30 17.10
Fibonacci 43.51 46.79 52.10 38.20 32.89 29.61 24.30
Camarilla 38.97 40.25 41.52 38.20 36.43 35.15 33.88

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      147.11
    • P/E
      -
    • Book Value (Rs)
      46.87
    • Dividend (%)
      -
    • Market Lot
      1
    • Industry P/E
      36.37
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      1.27
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      10.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      73.26
      5-Day
      76.20
      8-Day
      76.64
      92.91

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      147.11
    • P/E
      -
    • Book Value (Rs)
      -
    • Dividend (%)
      -
    • Market Lot
      1
    • Industry P/E
      36.37
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      -
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      -
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      73.26
      5-Day
      76.20
      8-Day
      76.64
      92.91

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Forum

Community Sentiments

  • 20% BUY
  • 40% SELL
  • 40% HOLD
40%
of moneycontrol users recommend selling Brooks Labs

What's your call on Brooks Labs today?

Read 3 investor views

BUY SELL HOLD

Action in Brooks Laboratories Ltd.

  • Only Buyers
    JUST NOW

    Only Buyers in Brooks Labs on NSE

    Sep 24, 10:05

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 23, 10:05

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 21, 10:05

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 18, 10:05

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 17, 11:20

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 16, 10:05

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Sep 15, 10:05

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Aug 20, 11:50

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Aug 18, 12:20

  • Only Buyers

    Only Buyers in Brooks Labs on BSE

    Aug 14, 10:45

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Aug 13, 12:45

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Aug 12, 13:15

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Aug 11, 13:25

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Aug 03, 15:10

  • Only Sellers

    Only Sellers in Brooks Labs on BSE

    Jul 31, 11:00

  • Only Sellers

    Only Sellers in Brooks Labs on NSE

    Jul 29, 10:15

  • Only Sellers

    Only Sellers in Brooks Labs on NSE

    Jul 28, 12:25

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Jul 27, 12:15

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Jul 24, 10:05

  • Only Buyers

    Only Buyers in Brooks Labs on NSE

    Jul 23, 10:05

Pre-Opening Session Prices9:00 am - 9:15 am

BSE

Sep 24, 09:15
58.35 1.60 (2.82%)
High 59.55
Low 58.35
Prev. Close 56.75
NSE - No shares traded

Financials

(Rs. Cr)
Quarterly JUN 2020 MAR 2020 DEC 2019 SEP 2019 JUN 2019
Sales
12 18 19 14 16
Other Income
0 0 0 0 0
Total Income
12 19 19 14 16
Total Expenditure
14 21 22 17 18
EBIT
-2 -2 -2 -3 -1
Interest
0 0 0 0 0
Tax
-- 12 -0 -2 1
Net Profit
-2 -15 -2 -1 -3

Historical Prices

On
Current Price %Gain / Loss
Open Price 31.27 58.35
86.6
High Price 32.85 59.55
81.28
Low Price 31.19 56.70
81.79
Close Price 31.98 56.75
77.45
Volume 17,801 35,566
99.8
On
Current Price %Gain / Loss
Open Price 31.63 58.30
84.32
High Price 32.88 59.30
80.35
Low Price 31.04 56.50
82.02
Close Price 31.84 56.50
77.45
Volume 25,397 73,769
190.46
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 10805.50 -326.40 -2.93
SENSEX 36553.60 -1114.82 -2.96
NIFTY BANK 20456.80 -721.70 -3.41
NIFTY IT 18973.00 -832.70 -4.20
S&P BSE Smallcap 14168.28 -331.25 -2.28
Index Price Change %Chg
CAC (Sep 24) 4,795.72 -6.54 -0.14
DAX (Sep 24) 12,656.80 13.83 0.11
FTSE (Sep 24) 5,875.08 -24.18 -0.41
Straits Times (Sep 24) 2,450.82 -30.32 -1.22
SGX Nifty (Sep 24) 10,805.50 -328.50 -2.95

CORPORATE ACTION

Date Agenda
Sep 15, 2020 Quarterly Results
Jul 30, 2020 Audited Results
Jul 21, 2020 Audited Results
Mar 03, 2020 Others
Feb 14, 2020 Quarterly Results
Type Dividend% Ex-Dividend date
No Dividends Information is available for Brooks Laboratories
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Brooks Laboratories
Old FV New FV Ex-Split
No Splits Information is available for Brooks Laboratories
Ratio Premium Ex-Bonus
9:20 10 Feb 11, 2020
Date Agenda
Sep 28, 2020 -
Sep 25, 2019 -
Jul 20, 2019 -
Aug 10, 2018 -
Sep 28, 2017 -

Dividend Summary

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone March 2020 December 2019 September 2019 June 2019
Promoters 66.41 62.58 62.58 60.62
Pledged 0 0 0 0
FII/FPI 0 0 0 0
Total DII 5.21 7.21 7.38 8.8
Fin.Insts 0 0.05 0 0.01
Insurance Co 0 0 0 0
MF 0 0 0 0
Others DIIs 5.21 7.16 7.38 8.79
Others 28.38 30.21 30.04 30.58
Total 100 100 100 100

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Brooks Labs 59.55 4.93 59.55 14.05 147.11 69.69 -24.38
Sun Pharma 485.40 -3.45 564.90 315.20 116463.72 12,531.93 3,211.14
Dr Reddys Labs 5060.00 -0.79 5514.65 2497.60 84125.03 11,850.40 2,937.70
Divis Labs 3032.00 -3.41 3388.00 1590.00 80490.07 5,310.57 1,372.71
Cipla 737.75 -3.80 819.00 356.75 59487.55 12,659.15 2,318.17

COMPANY OVERVIEW

Brooks Laboratories Limited (Brooks Laboratories) is a pharmaceutical contract research and manufacturing services company. It provides range of products catering to critical care segment in Parental Section, such as Beta Lactam, Cephalosporin and General Dry powder Injectables, Ampoules and Liquid vials, and Dry Syrups and Tablets. As of March 31, 2010, its product portfolio consist of 26 dry powder injections, 31 liquid injections, five tablets and two dry syrups. It manufactures a range of products on third party basis for companies, such as Zydus Cadila, Alembic, Intas, Wockhardt, Medley, Biochem, JB Chemical, PDPL and Sanat. Brooks Laboratories has a range of products catering to critical care segment in parental section, such as Beta Lactum, Cephalosporin, Carbapenems, General Dry powder Injectables and Liquid Injectables. Its Carbapenems products include Inj Ertapenem and Inj Meropenem. Its Liquid Injectables include Inj Nandrolone Decanoate, Inj Aceclofenac and Inj Midazolam.

COMPANY INFORMATION

  • Registered Office

  • Registrars

  • Management

    • Name

      Designation

    • Atul Ranchal

      Chairman

    • Rajesh Mahajan

      Managing Director

    • Rajnish Kumar Bedi

      Independent Director

    • Deepak Mahajan

      Independent Director

    • Sonia Gupta

      Independent Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Brooks Laboratories Ltd.

Brooks Labs is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 533543 and the NSE with an NSE Code of BROOKS.

Related Searches